Avivi I - Search Results

1

Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients.

Jurczyszyn A, Castillo JJ, Avivi I, Czepiel J, Davila J, Vij R, Fiala MA, Gozzetti A, Grząśko N, Milunovic V, Hus I, Mądry K, Waszczuk-Gajda A, Usnarska-Zubkiewicz L, Dębski J, Atilla E, Beksac M, Mele G, Sawicki W, Jayabalan D, Charliński G, Gyula Szabo A, Hajek R, Delforge M, Kopacz A, Fantl D, Waage A, Crusoe E, Hungria V, Richardson P, Laubach J, Guerrero-Garcia T, Liu J, Vesole DH. Jurczyszyn A, et al. Among authors: avivi i. Leuk Lymphoma. 2019 Jan;60(1):118-123. doi: 10.1080/10428194.2018.1473574. Epub 2018 Jul 2. Leuk Lymphoma. 2019. PMID: 29965787

2

A randomized study comparing yttrium-90 ibritumomab tiuxetan (Zevalin) and high-dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma.

Shimoni A, Avivi I, Rowe JM, Yeshurun M, Levi I, Or R, Patachenko P, Avigdor A, Zwas T, Nagler A. Shimoni A, et al. Among authors: avivi i. Cancer. 2012 Oct 1;118(19):4706-14. doi: 10.1002/cncr.27418. Epub 2012 Jan 17. Cancer. 2012. PMID: 22252613 Free article. Clinical Trial.

3

Allogeneic stem cell transplantation for patients with chronic myeloid leukemia: risk stratified approach with a long-term follow-up.

Zuckerman T, Katz T, Haddad N, Fineman R, Dann EJ, Avivi I, Ofran Y, Gavish I, Faibish T, Sahar D, Hertz E, Sabo E, Reisner Y, Rowe JM. Zuckerman T, et al. Among authors: avivi i. Am J Hematol. 2012 Sep;87(9):875-9. doi: 10.1002/ajh.23263. Epub 2012 Jul 27. Am J Hematol. 2012. PMID: 22847303 Free article. Clinical Trial.

4

Vaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patients.

Rosenblatt J, Avivi I, Vasir B, Uhl L, Munshi NC, Katz T, Dey BR, Somaiya P, Mills H, Campigotto F, Weller E, Joyce R, Levine JD, Tzachanis D, Richardson P, Laubach J, Raje N, Boussiotis V, Yuan YE, Bisharat L, Held V, Rowe J, Anderson K, Kufe D, Avigan D. Rosenblatt J, et al. Among authors: avivi i. Clin Cancer Res. 2013 Jul 1;19(13):3640-8. doi: 10.1158/1078-0432.CCR-13-0282. Epub 2013 May 17. Clin Cancer Res. 2013. PMID: 23685836 Free PMC article.

5

Genetic polymorphisms predicting methotrexate blood levels and toxicity in adult non-Hodgkin lymphoma.

Avivi I, Zuckerman T, Krivoy N, Efrati E. Avivi I, et al. Leuk Lymphoma. 2014 Mar;55(3):565-70. doi: 10.3109/10428194.2013.789506. Epub 2013 Aug 13. Leuk Lymphoma. 2014. PMID: 23829278

6

Is there a role for therapy response assessment with 2-[fluorine-18] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in mantle cell lymphoma?

Kedmi M, Avivi I, Ribakovsky E, Benyamini N, Davidson T, Goshen E, Tadmor T, Nagler A, Avigdor A. Kedmi M, et al. Among authors: avivi i. Leuk Lymphoma. 2014 Nov;55(11):2484-9. doi: 10.3109/10428194.2014.882506. Epub 2014 Mar 7. Leuk Lymphoma. 2014. PMID: 24432895

7

Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party.

Tanase A, Schmitz N, Stein H, Boumendil A, Finel H, Castagna L, Blaise D, Milpied N, Sucak G, Sureda A, Thomson K, Vandenberghe E, Vitek A, Dreger P; Lymphoma Working Party of the EBMT. Tanase A, et al. Leukemia. 2015 Mar;29(3):686-8. doi: 10.1038/leu.2014.280. Epub 2014 Sep 19. Leukemia. 2015. PMID: 25234166

8

Infections associated with bendamustine containing regimens in hematological patients: a retrospective multi-center study.

Gafter-Gvili A, Ribakovsky E, Mizrahi N, Avigdor A, Aviv A, Vidal L, Ram R, Perry C, Avivi I, Kedmi M, Nagler A, Raanani P, Gurion R. Gafter-Gvili A, et al. Among authors: avivi i. Leuk Lymphoma. 2016;57(1):63-9. doi: 10.3109/10428194.2015.1046862. Epub 2015 May 25. Leuk Lymphoma. 2016. PMID: 25944378

9

Reduced-dose ICE chemotherapy ± rituximab is a safe and effective salvage therapy for fit elderly patients with diffuse large B-cell lymphoma.

Sarid N, Joffe E, Gibstein L, Avivi I, Polliack A, Perry C, Herishanu Y. Sarid N, et al. Among authors: avivi i. Leuk Lymphoma. 2016 Jul;57(7):1633-9. doi: 10.3109/10428194.2015.1106532. Epub 2015 Dec 8. Leuk Lymphoma. 2016. PMID: 26643787

10

Primary failure of bortezomib in newly diagnosed multiple myeloma--understanding the magnitude, predictors, and significance.

Cohen YC, Joffe E, Benyamini N, Dimopoulos MA, Terpos E, Trestman S, Held-Kuznetsov V, Avivi I, Kastritis E. Cohen YC, et al. Among authors: avivi i. Leuk Lymphoma. 2016;57(6):1382-8. doi: 10.3109/10428194.2015.1121258. Epub 2016 Jan 4. Leuk Lymphoma. 2016. PMID: 26727104

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters